Amide proton transfer imaging might predict survival and IDH mutation status in high-grade glioma.

Objectives: To assess the utility of amide proton transfer (APT) imaging as an imaging biomarker to predict prognosis and molecular marker status in high-grade glioma (HGG, WHO grade III/IV).Methods: We included 71 patients with pathologically diagnosed HGG who underwent preoperative MRI with APT im...

Descripción completa

Detalles Bibliográficos
Publicado en:European Radiology Vol. 29; no. 12; pp. 6643 - 6653
Autores principales: Joo, Bio, Han, Kyunghwa, Ahn, Sung Soo, Choi, Yoon Seong, Chang, Jong Hee, Kang, Seok-Gu, Kim, Se Hoon, Zhou, Jinyuan, Lee, Seung-Koo
Formato: Journal Article
Publicado: Springer Nature Dec2019
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=139479342&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 139479342
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        09387994
        NPH
      jtl: European Radiology
      issn: 09387994
      maglogo: N
    pubinfo:
      dt: Dec2019
      vid: 29
      iid: 12
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        139479342
        139479342
        NLM31175415
        10.1007/s00330-019-06203-x
        NLM31175415
        139479342
      ppf: 6643
      ppct: 10
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Amide proton transfer imaging might predict survival and IDH mutation status in high-grade glioma.
      aug:
        au:
          Joo, Bio
          Han, Kyunghwa
          Ahn, Sung Soo
          Choi, Yoon Seong
          Chang, Jong Hee
          Kang, Seok-Gu
          Kim, Se Hoon
          Zhou, Jinyuan
          Lee, Seung-Koo
        affil: Department of Radiology and Research Institute of Radiological Science, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, 120-752, Seoul, South Korea
      sug:
        subj:
          Oxidoreductases
          Magnetic Resonance Imaging Methods
          DNA
          Brain Neoplasms
          Mutation
          Glioma
          South Korea
          Amides
          Prospective Studies
          Middle Age
          Sequence Analysis
          Glioma Mortality
          Brain Neoplasms Mortality
          Time Factors
          Female
          Oxidoreductases Metabolism
          Protons
          Glioma Diagnosis
          Brain Neoplasms Diagnosis
          Male
          Prognosis
          Survival Trends
          Scales
          Middle Aged: 45-64 years
          Female
          Male
      ab: Objectives: To assess the utility of amide proton transfer (APT) imaging as an imaging biomarker to predict prognosis and molecular marker status in high-grade glioma (HGG, WHO grade III/IV).Methods: We included 71 patients with pathologically diagnosed HGG who underwent preoperative MRI with APT imaging. Overall survival (OS) and progression-free survival (PFS) according to APT signal, clinical factors, MGMT methylation status, and IDH mutation status were analyzed. Multivariate Cox regression models with and without APT signal data were constructed. Model performance was compared using the integrated AUC (iAUC). Associations between APT signals and molecular markers were assessed using the Mann-Whitney test.Results: High APT signal was a significant predictor for poor OS (HR = 3.21, 95% CI = 1.62-6.34) and PFS (HR = 2.22, 95% CI = 1.33-3.72) on univariate analysis. On multivariate analysis, high APT signals were an independent predictor of poor OS and PFS when clinical factors alone (OS: HR = 2.89; PFS: HR = 2.13), or in combination with molecular markers (OS: HR = 2.85; PFS: HR = 2.00), were included as covariates. The incremental prognostic value of APT signals was significant for OS and PFS. IDH-wild type was significantly associated with high APT signals (p = 0.001) when compared to IDH-mutant; however, there was no difference based on MGMT methylation status (p = 0.208).Conclusion: High APT signal was a significant predictor of poor prognosis in HGG. APT data showed significant incremental prognostic value over clinical prognostic factors and molecular markers and may also predict IDH mutation status.Key Points: • Amide proton transfer (APT) imaging is a promising prognostic marker of high-grade glioma. • APT signals were significantly higher in IDH-wild type compared to IDH-mutant high-grade glioma. • APT imaging may be valuable for preoperative screening and treatment guidance.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N